Järve Apteegid OÜ

Active Registry code 14916257 OÜ Tallinn Registered 19 Feb 2020

Järve Apteegid OÜ is a OÜ based in Tallinn, registry code 14916257, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €1 304 572 with 24 employees.

Turnover

1 304 572 €

↓ 6.2% vs Q2 2026

State taxes

84 950 €

↑ 7.0% vs Q2 2026

Labour taxes

77 761 €

↑ 5.4% vs Q2 2026

Employees

±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Retail trade · EMTAK 47

Turnover · Q3 2026 1.3 mn €

above 98% of companies

industry median 23 652 € · companies in the industry: 7 652
Labour taxes per employee 3 240 €

above 90% of companies

industry median 1 201 € · companies in the industry: 4 663
Revenue · 2025 4.7 mn €

above 98% of companies

industry median 16 974 € · companies in the industry: 13 500
Net profit margin · 2025 -2.4 %

above 29% of companies

industry median 1.3 % · companies in the industry: 9 480

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € thousand Q3 2026: 1 304 572 € · −6.2% vs Q2 2026 · industry median 23 652 € · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 3 240 € · +5.4% vs Q2 2026 · industry median 1 201 € · above 90% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 24 · +0.0% vs Q2 2026

State taxes, € Q3 2026: 84 950 € · +7.0% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	1 304 572	84 950	77 761	24
Q2 2026	1 391 207	79 380	73 760	24
Q1 2026	1 384 045	92 659	73 488	24
Q4 2025	1 329 838	91 434	79 208	24
Q3 2025	1 119 975	88 636	75 766	24
Q2 2025	1 323 380	89 425	75 971	24
Q1 2025	1 297 034	87 318	76 158	24
Q4 2024	1 326 577	79 079	71 962	25
Q3 2024	1 075 459	82 419	73 488	24
Q2 2024	1 243 010	73 348	70 112	24
Q1 2024	1 176 110	81 632	71 132	24
Q4 2023	1 162 661	67 399	62 049	24
Q3 2023	842 251	55 902	55 131	21
Q2 2023	760 000	62 268	62 263	21
Q1 2023	1 127 814	79 143	67 406	21
Q4 2022	1 121 649	69 981	63 818	24
Q3 2022	978 511	70 225	66 954	24
Q2 2022	1 191 440	77 441	61 913	24
Q1 2022	1 193 480	74 512	56 380	23

Labour taxes per employee per month

1 080 €

Turnover per employee in the quarter

54 357 €

Q3 2026 · calculated from EMTA data

Financials by year

2020 – 2025

Revenue, € thousand 2025: 4 668 253 € · +3.7% vs 2024 · industry median 16 974 € · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: -110 017 € · +43.9% vs 2024 · industry median 0 € · above 2% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -2.4 % · +2.0 pp vs the year before · industry median 1.3 % · above 29% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 803 400 € · +16.1% vs 2024

Equity, € thousand 2025: -594 828 € · −22.7% vs 2024

Employees 2025: 20 · +0.0% vs 2024 · industry median 2 · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	4 668 253	-110 017	774 012	803 400	-594 828	20
2024	4 503 455	-196 279	725 651	691 975	-484 812	20
2023	3 600 714	-250 853	631 126	682 057	-288 532	19
2022	4 226 272	-77 116	657 658	690 683	-37 679	27
2021	4 060 442	34 584	532 583	533 446	39 437	23
2020	2 679 907	2 354	367 645	536 514	4 854	22

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

-2.4 %

Net profit / revenue

Return on assets (ROA)

-13.7 %

Net profit / assets

Equity ratio

-74.0 %

Equity / assets

Debt ratio

174.0 %

Liabilities / assets

Current ratio

0.57

Current assets / current liabilities

Revenue per employee

233 413 €

Revenue / average full-time employees

Labour cost per employee per month

3 225 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	30 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	30 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	30 Jun 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	30 Jun 2023	Company’s own · audited	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	30 Jun 2022	Company’s own	e-Äriregister
2020	19 Feb 2020 – 31 Dec 2020	30 Jun 2021	Company’s own	e-Äriregister

Board

Anu Kilk
Board member · since 19 Feb 2020

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Anu Kilk
Natural person · 2 500 €

100%

Beneficial owners

Anu Kilk
Direct ownership · since 19 Feb 2020

Founders and other persons

Anu Kilk
Founder · 2 500 € · 19 Feb 2020

Activities (EMTAK)

47731Retail sale of pharmaceutical products Main

Rulings 3

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 50140372 / M1 4 Aug 2025	Warning of compulsory dissolution: insufficient net assets	4 Feb 2026	Deficiencies eliminated 3 Feb 2026	PDF
Ä 50140372 / 2 1 Sep 2023	Amendment entry		In force 1 Sep 2023	PDF
Ä 50140372 19 Feb 2020	First entry		In force 19 Feb 2020	PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data